Medical/Pharmaceuticals
Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors
SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for Phase I/II clinical trial ofBRL03 for the treatment of lung cancer, gastric cancer and other ad...
2023-09-11 14:53
2306
PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)
IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical ...
2023-09-11 12:05
3651
Kidney Dialysis Foundation Unveils First In-Person 'Got To Walk 2023: Illuminating Life' Event To Raise Funds For Needy Kidney Patients
Illuminating the lives of needy kidney patients by walking together for a good cause. SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- The Kidney Dialysis Foundation (KDF) is thrilled to unveil the inaugural in-person edition of the 'Got To Walk 2023: Illuminating Life' walkathon, a flagship fundra...
2023-09-11 09:00
2404
Introducing BIOSTAR® cutting-edge Conventional TBNA (cTBNA) and Endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle: Revolutionizing Minimally Invasive Diagnostic techniques
SAN JOSE, Calif., Sept. 9, 2023 /PRNewswire/ -- In a remarkable stride towards advancing medical technology, we are thrilled to announce the launch of our groundbreaking BioStar® Transbronchial Aspiration Needle (TBNA) designed to transform the landscape of minimally invasive diagnostics. This in...
2023-09-09 01:30
3343
Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm
Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusiv...
2023-09-08 22:45
2928
Omega Healthcare Celebrates 20 Years of Excellence and Innovation in Healthcare Outsourcing Solutions
Two decades of empowering healthcare organizations to deliver exceptional care and enhance their financial performance BOCA RATON, Fla., Sept. 8, 2023 /PRNewswire/ -- Omega Healthcare, a leading healthcare company, is excited to announce the celebration of its 20th anniversary. This significant ...
2023-09-08 21:00
2574
Nobel Trust Family Joins BIOHK2023 - Unveiling Key Announcement
HONG KONG, Sept. 8, 2023 /PRNewswire/ -- BIOHK2023 garnered widespread acclaim featuring an exceptional lineup of speakers, including aNobel Laureate, world-renowned scientists who have won distinguished awards, and accomplished biotech C-level venture capitalists taking the stage on 13th to 16th...
2023-09-08 16:30
3294
The Li Shu Fan Medical Foundation Donates £1 Million to Establish the RCSEd Dr Li Shu Fan International Professorship
Fostering Medical Research and Knowledge Transfer that Transcend Borders HONG KONG, Sept. 8, 2023 /PRNewswire/ -- The Li Shu Fan Medical Foundation (the Foundation) and theRoyal College of Surgeons of Edinburgh (RCSEd) today made an announcement regarding a donation of £1 million (equivalent to ...
2023-09-08 16:01
3746
Exploring why rates of cardiovascular disease and earlier onset are increasing in women
ADELAIDE, Australia, Sept. 8, 2023 /PRNewswire/ -- Advanced research is casting light on possible early life factors – including poverty, physical or mental abuse – that may impact the rate of egg loss and increase the risk of cardiovascular disease in post-menopausal women. Traditionally, ca...
2023-09-08 14:31
3291
SIFI TO PRESENT NEW SCIENTIFIC DATA DURING THE 41ST CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS
CATANIA, Italy, Sept. 8, 2023 /PRNewswire/ -- SIFI, a leading international ophthalmic company, is pleased to announce the presentation of new scientific data on its products during the upcomingCongress of The European Society of Cataract and Refractive Surgeons (ESCRS) which will take place from...
2023-09-08 14:00
3514
Assure Family Clinic - An Integrative GP Clinic That Aims To Enhance Your Physical And Mental Wellbeing
The one-stop clinic located in Bukit Merah Central offers a full range of GP services for adults and children, as well as health and wellness screening. SINGAPORE, Sept. 8, 2023 /PRNewswire/ -- Based on the principles of integrative medicine, Assure Family Clinic takes the 'whole person' approach...
2023-09-08 11:30
2899
Adagene to Present at Investor and Scientific Conferences in September
- Adagene's CEO and President of R&D, Dr. Peter Luo, participating in SITC webinar onSeptember 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies - SAN DIEGO and SUZHOU, China, Sept. 8, 2023 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a platform-driven, clinic...
2023-09-08 10:45
3525
Australian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE™ Award for Duchenne Muscular Dystrophy
- Grant funding will support Save our Sons Duchenne Foundation in developing a digital health app - SYDNEY, Sept. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that an Australian patient advocacy organization is one of the two recipients of the company's 2023 STRI...
2023-09-07 20:00
2715
Clarius Applauded by Frost & Sullivan with the Company of the Year Award for Its Handheld Ultrasound Systems and Market-leading Position
Clarius has become a notable player in the industry with the ability to deliver exceptional hospital-grade performance cost-effectively. SAN ANTONIO, Sept. 7, 2023 /PRNewswire/ -- Recently, Frost & Sullivan assessed the ultraportable ultrasound industry and, based on its findings, recognizesClar...
2023-09-07 20:00
2081
TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in Neurological Care and Its Market-leading Position
TeraRecon partners with different vendors to provide precise, AI-supported patient care and expand in the neurological solutions market and other disease areas, improving patient outcomes. SAN ANTONIO, Sept. 7, 2023 /PRNewswire/ -- Recently, Frost & Sullivan researched the AI-based neurological ...
2023-09-07 20:00
2136
World Health Summit 2023 with 20 ministers from all over the world in Berlin from October 15-17
Press accreditation open for the world's leading global health conference BERLIN, Sept. 7, 2023 /PRNewswire/ -- The World Health Summit 2023 from October 15-17 in Berlin will bring together the most prominent names in global health from all sectors in all regions of the world. Speakers will inclu...
2023-09-07 19:16
1882
The 2nd Global ADC and XDC Innovation Conference will be held in Wuxi in September
SHANGHAI, Sept. 7, 2023 /PRNewswire/ -- The 2nd Global ADC and XDC Innovation
Conference (Global XDC 2023) will be held in Wuxi,China on Sept 21st-22nd, 2023
. The conference is supported by Wuxi High-tech Zone Administrative Committee,
WuXi Biologics, Wuxi XDC, and BioValley.
2023-09-07 17:25
2277
Untangling the enigma of PCOS and its distressing impacts in 12 per cent of women
ADELAIDE, Australia, Sept. 7, 2023 /PRNewswire/ -- Psychological issues including anxiety, depression and negative body image are adding to the physical burden of polycystic ovary syndrome (PCOS), a hormonal disorder that affects 12 per cent of women globally. International research has reveal...
2023-09-07 09:36
2756
Imaging Endpoints Appoints Manish Sharma, MD as Chief Scientific Officer
SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment ofManish Sharma, MD as its Chief Scientific Officer. Dr Sharma, a radiologist with over...
2023-09-06 21:00
3401
Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty Surgery.
SAN JOSE, Sept. 6, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced positive topline results from its Phase 2 proof of concept study of TPU-006, a 4-day dexmedetomidine transdermal patch for Post Surgical Pain. The double-blind, placebo-controlled, single-...
2023-09-06 20:06
2682
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 283 media titles]
2026-10-19 13:18
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 277 media titles]
2026-10-23 21:52
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 276 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
26993
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
22645
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
21112
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
20567